Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1387.00
7.00
(0.51%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy's gets marketing authorization for generic semaglutide injection in Brazil
>>
Dr. Reddy's Laboratories rises on securing USFDA’s tentative approval for injectable lenacapavir
>>
Dr. Reddy's Laboratories secures USFDA’s tentative approval for injectable lenacapavir
>>
Dr Reddy's Laboratories trades higher on the BSE
>>
Dr Reddy's Laboratories' Srikakulam unit gets USFDA’s VAI classification
>>
Dr. Reddy’s Laboratories reports 31% fall in Q2 consolidated net profit
>>
Dr. Reddy's Labs. - Quaterly Results
>>
Dr. Reddy’s Laboratories gets nod for Zytorvi in advanced esophageal cancer
>>
Dr. Reddy’s Laboratories informs about press release
>>
USFDA completes pre-approval inspection at Dr. Reddy’s Visakhapatnam facility
<<
<
1
2
3
...145
>
>>